Correlation of in vitro T-Cell and B-Cell function with responses to childhood vaccines in children with human immunodeficiency virus infection

Viral Immunology

Volumn 10, Issue 4, 1997, Pages 197-206

  Peters, Vicki B ^a   Mayer, Lloyd F ^a   Sperber, Kirk E ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; CANDIDA ANTIGEN; CD4 ANTIGEN; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE VACCINE; HEPATITIS B VACCINE; MITOGENIC AGENT; TETANUS TOXOID; VACCINE;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CLINICAL ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; T LYMPHOCYTE; VACCINATION;

CANDIDA; HAEMOPHILUS; HAEMOPHILUS INFLUENZAE SEROTYPE B; HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0031431305     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1997.10.197     Document Type: Article

References (27)

1. Arpadi S.M., S. Back, J. O'Brien, and E.N. Janoff. 1994. Antibodies to pneumococcal capsular polysaccharides in children with human immunodeficiency virus infection given polyvalent pneumococcal vaccine. J. Pediatr. 125:77-79.
2. Bernstein, L.J., H.D. Ochs, R.J. Wedgwood, and A. Rubinstein. 1985. Defective humoral immunity in pediatric acquired immune deficiency syndrome. J. Pediatr. 107:352-357.
3. Bernstein, D.I., V.E. Smith, G.M. Schiff, H.M. Rathfon, and J.A. Boscia. 1993. Comparison of acellular pertussis vaccine with whole cell vaccine as a booster in children 15 to 18 months and 4 to 6 years of age. Pediatr. Infect. Dis. J. 12:131-135.
4. Black, S.B., H.R. Shinefield, D. Lampert, B. Fireman, R.A. Hiatt, M. Polen, E. Vittinghoff, and the Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. 1991. Safety and immunogenicity of oligosaccharide conjugate H. influenzae type b (HbOC) in infancy. Pediatr. Infect. Dis. J. 10:92-96.
5. Borkowsky, W., M. Rigaud, K. Krasinski, T. Moore, R. Lawrence, and H. Pollack. 1992. Cell-mediated and humoral immune responses in children infected with human immunodeficiency virus during the first four years of life. J. Pediatr. 120:371-375.
6. Boue, F., C. Wallon, C. Goujard, F. Barre-Sinoussi, P. Galanaud, and J.F. Delfraissy. 1992. HIV induces IL-6 production by human B lymphocytes. Role of IL-4. J. Immunol. 148:3761-3767.
7. Centers for Disease Control and Prevention. 1994. Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 43(RR-12):1-10.
8. Centers for Disease Control. 1991. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus. MMWR 40(RR-2):1-13.13.
9. Chadwick, E.G., G. Chang, M.D. Decker, R. Yogev, D. Dimichele, and K.M. Edwards. 1994. Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children. Pediatr. Infect. Dis. J. 13:206-211.
10. Chirmule, N., M. Lesser, A. Gupta, M. Ravipati, N. Kohn, and S. Pahwa. 1995. Immunological characteristics of HIV-infected children: relationship to age, CD4 counts, disease progression, and survival. AIDS Res. Hum. Retro-viruses 11:1209-1219.
11. Choudhury, S.A., and V.B. Peters. 1995. Responses to hepatitis B vaccine boosters in human immunodeficiency virus-infected children. Pediatr. Infect. Dis. J. 14:65-67.
12. Clerici, M., T.A. Wynn, J.A. Berzofsky, S.P. Blatt, C.W. Hendrix, A. Sher, R.L. Coffman, and G.M. Shearer. 1996. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with human immunodeficiency virus. J. Clin. Invest. 93:768-775.
13. Clerici, M., F.T. Hakim, D.J. Venzon, S. Blatt, C.W. Hendrix, T.A. Wynn, and G.M. Shearer. 1995. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91:759-765.
14. Dankner, W.M. 1995. Bacterial infections in HIV-infected children. Semin. Pediatr. Infect. Dis. 6:3-9.
15. Diamant, E.P., C. Schechter, D.S. Hodes, and V.B. Peters. 1993. Immunogenicity of hepatitis B vaccine in human immunodeficiency virus-infected children. Pediatr. Infect. Dis. J. 12:877-888.
16. Erkeller-Yuksel, P.M., V. Deneys, B. Yuksel, I. Hannet, F. Hulstaert, C. Hamilton, H. Mackinnon, L. Turner-Stokes, V. Munhyeshull, F. Vanlangendonck, M. De Bruyère, B.A. Back, and P.M. Lydyard. 1992. Age-related changes in human blood lymphocyte subpopulations. J. Pediatr. 120:216-222.
17. Greenberg, D.P. 1993. Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies. Pediatr. Infect. Dis. J. 12:438-445.
18. Halperin, S.A., I. Barreto, B.J. Eastwood, B. Law, and E.A. Roberts. 1994. Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities. Arch. Pediatr. Adolesc. Med. 148:1220-1224.
19. Johnson, J.P., R. Hebel, and R. Shinaberry. 1991. Lymphoproliferative responses to mitogen and antigen in HIV-infected children. AIDS Res. Hum. Retroviruses 7:781-786.
20. Kale, K.L., J.C. King, J.J. Farley, P.E. Vink, C.O. Cimino, and P.R. Paradiso. 1995. The immunogenicity of Haemophilus influenzae type b conjugate (HbOC) vaccine in human immunodeficiency virus-infected and uninfected infants. Pediatr. Infect. Dis. J. 14:350-354.
21. Lane, H.C., H. Masur, L.C. Edgar, G. Whalen, A.H. Rook, and A.S. Fauci. 1983. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immune deficiency syndrome. N. Engl. J. Med. 309:453-458.
22. 197 conjugate vaccine in infants aged 15 to 23 months. Pediatrics 86:527-534.
23. Pahwa, S., S. Fikrig, R. Menez, and R. Pahwa. 1986. Pediatric acquired immunodeficiency syndrome: demonstration of B lymphocyte defects in vitro. Diagn. Immunol. 4:24-30.
24. Palumbo, P., L. Hoyt, K. Demasio, J. Oleske, and E. Connor. 1992. Population-based study of measles and measles immunization in human immunodeficiency virus-infected children. Pediatr. Infect. Dis. J. 11:1008-1114.
25. Peters, V.B., and S.K. Sood. 1994. Immunity to Haemophilus influenzae type b polysaccharide capsule in children with human immunodeficiency virus infection immunized with a single dose of a Haemophilus vaccine. J. Pediatr. 125:74-77.
26. 197 conjugate vaccine in infants with human immunodeficiency virus infection. J. Pediatr. 128:363-365.
27. 197 conjugate vaccine in children with human immunodeficiency virus infection. Pediatr. Infect. Dis. J. 16:711-713.